NORTH AMERICA CIC DRUG MARKET FORECAST 2018-2026
[vc_row][vc_column width=”3/4″][vc_message] The North America chronic idiopathic constipation drug market was valued to be at $xx million in the year 2017. The market is further projected to rise at a CAGR of 6.95 % during the forecast years of 2018-2026. Growing elderly population, efficient drugs in the pipeline and the rising constipation problems due to…